Home  |  繁體  |  簡体
       
  Bloomage BioTechnology Corporation Limited was incorporated in Caymans Island on 3 April 2006. It holds 100% equity interest of two companies – Valuerank Holdings Limited and Farstar Enterprises Limited – which were both incorporated in the British Virgin Islands. ...more  

Interim Report

 
12-04-2017
 

Announcements and Notices - Change of Company Name of Principal Share Registrar and Transfer Office in the Cayman Islands

05-04-2017
 

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2017

22-03-2017
 

Announcements and Notices - Results Announcement for the Year Ended 31 December 2016

 
HA End Products - Medical device products
The injectable hyaluronan soft tisse filling gel (Trademark: BioHyalux) is the end product the Group launched in the market in 2012. Also, we have reserved products known as the medical use sodium hyaluronate gel (Trademark: HYMOIS) and the intra-articular injection (Trademark: Hyprojoint) and so forth.
To learn more……
HA Raw Materials
The HA Materials are produced by microbial fermentation, using non-genetically modified strains from non-animal sources. The products are safe, pure and stable.
To learn more……
Links to related companies
Bloomage Freda Biopharm Co., Ltd
Beijing Bloomage Hyinc Technology Co., Ltd